References
- Deininger MW. Milestones and monitoring in patients with CML treated with imatinib. Hematology Am Soc Hematol Educ Program 2008:419–426.
- Breccia M, Salaroli A, Molica M, et al. Systematic review of dasatinib in chronic myeloid leukemia. Onco Targets Ther 2013;6:257–265.
- Cortes J, O’Brien S, Ault P, et al. Pregnancy outcomes among patients with chronic myeloid leukemia treated with dasatinib. Blood 2008;112(Suppl. 1): Abstract 3230.
- Oweini H, Otrock ZK, Mahfouz RA, et al. Successful pregnancy involving a man with chronic myeloid leukemia on dasatinib. Arch Gynecol Obstet 2011;283:133–134.
- O’Hare T, Walters DK, Stoffregen EP, et al. In-vitro activity of Bcr-Abl inhibitors AMN107 and BMS-354825 against clinically relevant imatinib-resistant Abl kinase domain mutants. Cancer Res 2005;65:4500–4505.
- Investigators’ brochure, STI 571 (formerly CGP 57148B), and data on file. Novartis Pharma AG, Basel, Switzerland.
- Ault P, Kantarjian H, O’Brien S, et al. Pregnancy among patients with chronic myeloid leukemia treated with imatinib. J Clin Oncol 2006;24:1–5.
- Pye SM, Cortes J, Ault P, et al. The effects of imatinib on pregnancy outcome. Blood 2008;111:5505–5508.
- Highlights of prescribing information: Sprycel. Available from: http://packageinserts.bms.com/pi/pi_sprycel.pdf
- Conchon M, Sanabani SS, Serpa M, et al. Successful pregnancy and delivery in a patient with chronic myeloid leukemia while on dasatinib therapy. Adv Hematol 2010;2010:136252.
- Kroll T, Ames MB, Pruett JA, et al. Successful management of pregnancy occurring in a patient with chronic myeloid leukemia on dasatinib. Leuk Lymphoma 2010;51:1751–1753.
- Bayraktar S, Morency B, Escalón MP. Successful pregnancy in a patient with chronic myeloid leukaemia exposed to dasatinib during the first trimester. BMJ Case Rep 2010;2010. pii: bcr0520102975.
- American College of Obstetricians and Gynecologists. Placenta accreta. Committee Opinion No. 529. Obstet Gynecol 2012;120: 207–211.